Incretin hormones and beta-cell mass expansion: What we know and what is missing?

Archives of Physiology and Biochemistry

Volumn 119, Issue 4, 2013, Pages 161-169

  Tortosa, Federica ^a   Dotta, Francesco ^b,c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Fondazione Umberto Di Mario ONLUS ^*  (Italy)

Author keywords

Beta cell mass; Cell death; Incretin hormones; Neogenesis; Proliferation

Indexed keywords

INCRETIN;

ANIMAL; ARTICLE; CELL COUNT; CELL DEATH; CYTOLOGY; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOLOGY;

ANIMALS; CELL COUNT; CELL DEATH; DIABETES MELLITUS, TYPE 2; HUMANS; INCRETINS; INSULIN-SECRETING CELLS;

EID: 84884806808     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2013.795175     Document Type: Article

References (141)

1. Abraham EJ, Leech CA, Lin JC, et al. (2002). Insulinotropic hormone glucagon like peptide-1 differentiation of human pancreatic isletderived progenitor cells into insulin producing cells. Endocrinology, 143:3152-61
2. Agersøh; H, Jensen LB, Elbrøh;nd B, et al. (2002). The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new longacting GLP-1 derivative, in healthy men. Diabetologia, 45:195-202
3. Ahren B, Carr RD, Deacon CF. (2010). Incretin hormone secretion over the day. Vitam Horm, 84:203-20
4. Ahren B. (2003). Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep, 3:365-72
5. Arakawa M, Ebato C, Mita T, et al. (2009). Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. Biochem Biophys Res Commun, 390:809-14
6. Arnette D, Gibson TB, Lawrence MC, et al. (2003). Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem, 278:32517-25
7. Baggio LL, Drucker DJ. (2007). Biology of incretins: GLP-1 andGIP. Gastroenterology, 132:2131-57
8. Bastien-Dionne PO, Valenti L, Kon N, et al. (2011). Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic b-cell mass expansion. Diabetes, 60:3217-22
9. Bocker D, Verspohl EJ. (2001). Role of protein kinase C, PI3-kinase and tyrosine kinase in activation of MAP kinase by glucose and agonists of G-protein coupled receptors in INS-1 cells. Int J Exp Diabetes Res, 2:233-44
10. Bonner-Weir S. (2000). Life and death of the pancreatic beta cells. Trends Endocrinol Metab, 11:375-8
11. Bonner-Weir S, Weir GC. (2005). New sources of pancreatic beta-cells. Nat Biotechnol, 23:857-61
12. Brennand K, Huangfu D, Melton D. (2007). All beta cells contribute equally to islet growth and maintenance. PLoS Biology, 5:e163
13. Brissova M, Fowler MJ, Nicholson WE, et al. (2005). Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem, 53:1087-97
14. Brüning JC, Winnay J, Bonner-Weir S, et al. (1997). Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell, 88:561-72
15. Buse JB, Rosenstock J, Sesti G, et al; LEAD-6 Study Group. (2009). Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, openlabel trial (LEAD-6). The Lancet, 374:39-47
16. Buteau J, Foisy S, Joly E, Prentki M. (2003). Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes, 52:124-32
17. Buteau J, El-Assaad W, Rhodes CJ, et al. (2004). Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia, 47:806-15
18. Butler AE, Janson J, Bonner-Weir S, et al. (2003). Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52:102-10
19. Cabrera O, Berman DM, Kenyon NS, et al. (2006). The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA, 103:2334-9
20. Cano DA, Rulifson IC, Heiser PW, et al. (2008). Regulated b-cell regeneration in the adult mouse pancreas. Diabetes, 57:958-66
21. Chae HY, Kang JG, Kim CS, et al. (2012). Effect of glucagon-like peptide-1 gene expression on graft function in mouse islet transplantation. Transpl Int, 25:242-9
22. Chia CW, Egan JM. (2008). Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab, 93:3703-16
23. Cho H, Mu J, Kim JK, et al. (2001). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBb). Science, 292:1728-31
24. Chung CH, Hao E, Piran R, et al. (2010). Pancreatic b-cell neognesis by direct conversion from mature a-cells. Stem Cells, 28:1630-38
25. Cnop M, Welsh N, Jonas JC, et al. (2005). Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes, 54:S97-107
26. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, et al. (2006). Molecular control of cell cycle progression in the pancreatic b-cell. Endocr Rev, 27:356-70
27. Cunha DA, Ladrière L, Ortis F, et al. (2009). Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes, 58: 2851-62
28. D'Amico E, Hui H, Khoury N, et al. (2005). Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs. J Mol Endocrinol, 34:377-90
29. Deacon CF, Johnsen AH, Holst JJ. (1995a). Degradation of glucagonlike peptide-1 by human plasma in vitro yields an N-Terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab, 80:952-7
30. Deacon CF, Nauck MA, Toft-Nielsen M, et al. (1995b). Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-Terminus in type II diabetic patients and in healthy subjects. Diabetes, 44:1126-31
31. Deacon CF, Ahrén B. (2011). Physiology of incretins in health and disease. Rev Diabet Stud, 8:293-306
32. Del Guerra S, Lupi R, Marselli L, et al. (2005). Functional and molecular alterations of pancreatic islets in human Type 2 diabetes. Diabetes, 54:727-35
33. Donath MY, Halban PA. (2004). Decreased beta-cell mass in diabetes: Significance, mechanisms and therapeutic implications. Diabetologia, 47:581-9
34. Donath MY, Ehses JA, Maedler K, et al. (2005). Mechanisms of beta-cell death in type 2 diabetes. Diabetes, 54:S108-13
35. Dor Y, Brown J, Martinez OI, Melton DA. (2004). Adult pancreatic betacells are formed by self-Duplication rather than stem-cell differentiation. Nature, 429:41-6
36. Dor Y, Melton DA. (2008). Facultative endocrine progenitor cells in the adult pancreas. Cell, 132:183-4
37. Drucker DJ, Philippe J, Mojsov S, et al. (1987). Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA, 84:3434-8
38. Drucker DJ. (2002). Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology, 122:531-44
39. Dunlop M, Muggli E, Clark S. (1996). Association of cyclin-Dependent kinase-4 and cyclin D1 in neonatal b cells after mitogenic stimulation by lysophosphatidic acid. Biochem Biophys Res Commun, 218:132-6
40. Ebato C, Uchida T, Arakawa M, et al. (2008). Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab, 8:325-32
41. Ehses JA, Pelech SL, Pederson RA, McIntosh CH. (2002). Glucosedependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMPdependent protein kinase/ Rap1-mediatedpathway. J Biol Chem, 277:37088-97
42. Ehses JA, Casilla VR, Doty T, et al. (2003). Glucose-Dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogenactivated protein kinase. Endocrinology, 144:4433-45
43. Elliott RM, Morgan LM, Tredger JA, et al. (1993). Glucagon-like peptide-1 (7-36) amide and glucose-Dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute postprandial and 24-h secretion patterns. J Endocrinol, 138:159-66
44. Elrick H, Stimmler L, Hlad Jr. Cj, Arai Y. (1964). Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab, 24:1076-82
45. Farilla L, Hui H, Bertolotto C, et al. (2002). Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology, 143:4397-408
46. Fehmann HC, Goke R, Goke B. (1995). Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucosedependent insulin releasing polypeptide. Endocr Rev, 16:390-410
47. Friedrichsen BN, Neubauer N, Lee YC, et al. (2006). Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol, 188:481-92
48. Georgia S, Bhushan A. (2004). Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest, 114:963-8
49. Gepts W, Lecompte PM. (1981). The pancreatic islets in diabetes. Am J Med, 70:105-15
50. Gonzalez CD, Lee MS, Marchetti P, et al. (2011). The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy, 7: 2-11
51. Gupta RK, Gao N, Gorski RK, et al. (2007). Expansion of adult b-cell mass in response to increasedmetabolic demand is dependent on HNF-4a. Genes Dev, 21:756-69
52. Halban PA. (2004). Cellular sources of new pancreatic beta-cells and therapeutic implications for regenerative medicine. Nat Cell Bio, 6: 1021-5
53. Heit JJ, Apelqvist AA, Gu X, et al. (2006a). Calcineurin/NFAT signalling regulates pancreatic betA-cell growth and function. Nature, 443:345-9
54. Heit JJ, Karnik SK, Kim SK. (2006b). Intrinsic regulators of pancreatic beta-cell proliferation. Ann Rev Cell Dev Biol, 22:311-38
55. Herbach N, Bergmayr M, Göke B, et al. (2011). Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice. PLoS One [Online] Available at: Http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0022814. [last accessed 26Jul 2011].
56. Hui H, Wright C, Perfetti R. (2001). Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes, 50:785-96
57. Hui H, Perfetti R. (2002). Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol, 146:129-41
58. Hui H, Nourparvar A, Zhao X, Perfetti R. (2003). Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 50-Adenosine monophosphatedependent protein kinase A-And a phosphatidylinositol 3-kinase-Dependent pathway. Endocrinology, 144: 1444-55
59. Ichii H, Inverardi L, Pileggi A, et al. (2005). A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant, 5:1635-45
60. Igoillo-Esteve M, Marselli L, Cunha DA, et al. (2010). The inflammatory response of human pancreatic b-cells in type 2 diabetes is mimicked by in vitro exposure to palmitate. Diabetologia, 53: 1395-405
61. Jang HJ, Kokrashvili Z, Theodorakis MJ, et al. (2007). Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA, 104:15069-74
62. Jung HS, Lee MS. (2009). Macroautophagy in homeostasis of pancreatic b-cell. Autophagy, 5:241-3
63. Kashima Y, Miki T, Shibasaki T, et al. (2001). Critical role of cAMPGEFII-Rim2 complex in incretinpotentiated insulin secretion. J Biol Chem, 276:46046-53
64. Kim SJ, Winter K, Nian C, et al. (2005). Glucose-Dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem, 280:22297-307
65. Kim SJ, Nian C, Widenmaier S, McIntosh CH. (2008). Glucose-Dependent insulinotropic polypeptide mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) andcAMP-responsiveCREB coactivator 2. Mol Cell Biol, 28:1644-56
66. Kolterman OG, Kim DD, Shen L, et al. (2005). Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm, 62:173-81
67. Knudsen LB, Nielsen PF, Huusfeldt PO, et al. (2000). Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J Med Chem, 43:1664-9
68. Kubota A, Yamada Y, Yasuda K, et al. (1997). Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and-insensitive pathways. Biochem Biophys Res Commun, 235:171-5
69. Kulkarni RN, Jhala US, Winnay JN, et al. (2004). PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest, 114:828-36
70. Kwon G, Pappan KL, Marshall CA, et al. (2004). cAMP dosedependently prevents palmitate induced apoptosis by both protein kinase A-And cAMP-guanine nucleotide exchange factor dependent pathways in beta-cells. J Biol Chem, 279:8938-45
71. Lambeir AM, Durinx C, Scharpé S, De Meester I. (2003). Dipeptidylpeptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci, 40:209-94
72. Lee YC, Nielsen JN. (2009). Regulation of beta cell replication. Molecular and Cellular Endocrinology, 297:18-27
73. Levine B, Kroemer G. (2008). Autophagy in the pathogenesis of disease. Cell, 132:27-42
74. Li L, Lili R, Hui Q, et al. (2008). Combination of GLP-1 and sodium butyrate promote differentiation of pancreatic progenitor cells into insulin-producing cells. Tissue Cell, 40:437-45
75. Madsen K, Knudsen LB, Agersoe H, et al. (2007). Structure-Activity and protraction relationship of long-Acting glucagon-like peptide-1 derivatives: Importance of fatty acid length, polarity, and bulkiness. J Med Chem, 29:6126-32
76. Maida A, Hansotia T, Longuet C, et al. (2009). Differential importance of glucosedependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice. Gastroenterology, 137:2146-57
77. Marchetti P, Del Guerra S, Marselli L, et al. (2004). Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab, 89:5535-41
78. Marchetti P, Dotta F, Lauro D, Purrello F. (2008). An overview of pancreatic beta-cell defects in human type 2 diabetes: Implications for treatment. Regul Pept, 146:4-11
79. Marchetti P, Lupi R, Bugliani M, et al. (2009). Autophagy and the pancreatic beta-cell in human type 2 diabetes. Autophagy, 5:1055-6
80. Marchetti P, Lupi R, Bugliani M, et al. (2012). A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia, 55:3262-72
81. Marsh BJ, Soden C, Alarcón C, et al. (2007). Regulated autophagy controls hormone content in secretory-Deficient pancreatic endocrine b-cells. Mol Endocrinol, 21:2255-69
82. Martin J, Hunt SL, Dubus P, et al. (2003). Genetic rescue of Cdk4 null mice restores pancreatic.-cell proliferation but not homeostatic cell number. Oncogene, 22:5261-69
83. Mayo KE, Miller LJ, Bataille D, et al. (2003). International union of pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev, 55:167-94
84. McIntyre N, Holdsworth Cd, Turner Ds. (1964). New interpretation of oral glucose tolerance. Lancet, 2:20-1
85. Meier JJ, Bhushan A, Butler AE, et al. (2005). Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration? Diabetologia, 48:2221-8
86. Meier JJ, Butler AE, Saisho Y, et al. (2008). Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes, 57:1584-94
87. Mojsov S, Heinrich G, Wilson IB, et al. (1986). Preproglucagon gene expression in pancreas and intestine diversifies at the level of posttranslational processing. J Biol Chem, 261:11880-9
88. Montrose-Rafizadeh C, Wang Y, Janczewski AM, et al. (1997). Overexpression of glucagon-like peptide-1 receptor in an insulinsecreting cell line enhances glucose responsiveness. Mol Cell Endocrinol, 130:109-17
89. Mortensen K, Christensen LL, Holst JJ, Orskov C. (2003). GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept, 114:189-96
90. Nagaya M, Katsuta H, Kaneto H, et al. (2009). Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J Endocrinol, 201:37-47
91. Natalicchio A, De Stefano F, Orlando MR, et al. (2010). Exendin-4 prevents c-Jun N-Terminal protein kinase activation by tumor necrosis factor-Alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells. Endocrinology, 151:2019-29
92. Nauck MA, Heimesaat MM, Orskov C, et al. (1993). Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest, 91:301-7
93. Nauck MA. (2011). Incretin-based therapies for type 2 diabetes mellitus: Properties, functions, and clinical implications. Am J Med, 124:S3-18
94. Nir T, Melton DA, Dor Y. (2007). Recovery from diabetes in mice by b cell regeneration. J Clin Inv, 117:2553-61
95. Ogino J, Sakurai K, Yoshiwara K, et al. (2006). Insulin resistance and increased pancreatic b-cell proliferation in mice expressing a mutant insulin receptor (P1195L). J Endocrinol, 190:739-47
96. Okada T, Liew CW, Hu J, et al. (2007). Insulin receptors in b-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA, 104:8977-82
97. Orskov C, Wettergren A, Holst JJ. (1996). Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol, 31:665-70
98. Pandey UB, Nie Z, Batlevi Y, et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature, 447:859-63
99. Parsons JA, Brelje TC, Sorenson RL. (1992). Adaptation of islets of Langerhans to pregnancy: Increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology, 130:1459-66
100. Parsons JA, Bartke A, Sorensons RL. (1995). Number and size of islets of Langehans in pregnancy, human growth hormone-expressing transgenic and pituitary dwarf mice: Effect of lactogenic hormones. Endocrinology, 136:2013-21
101. Perfetti R, Zhou J, Doyle ME, Egan JM. (2000). Glucagon-like peptide-1 induces cell proliferation and pancreatic-Duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology, 141:4600-5
102. Poitout V. (2013). Lipotoxicity impairs incretin signalling. Diabetologia, 56:231-3
103. Prentki M, Nolan CJ. (2006). Islet b cell failure in type 2 diabetes. J Clin Invest, 116:1802-12
104. Rane SG, Dubus P, Mettus RV, et al. (1999). Loss of Cdk4 expression causes insulin-Deficient diabetes and Cdk4 activation results in beta islet cell hyperplasia. Nat Genet, 22:44-52
105. Rhodes CJ. (2005). Type 2 diabetes-A matter of beta-cell life and death? Science, 307: 380-84
106. Rieck S, Kaestner KH. (2010). Expansion of b-cell mass in response to pregnancy. Trends Endocrinol Metabol, 21:151-8
107. Rozengurt N, Wu SV, Chen MC, et al. (2006). Colocalization of the alpha-subunit of gustducin with PYY and GLP-1 in L cells of human colon. Am J Physiol Gastrointest Liver Physiol, 291: G792-802
108. Seeberger KL, Dufour JM, Shapiro AM, et al. (2006). Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest, 86:141-53
109. Simonsen L, Holst JJ, Deacon CF. (2006). Exendin-4, but not glucagonlike peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs. Diabetologia, 49:706-12
110. Stoffers DA, Kieffer TJ, Hussain MA, et al. (2000). Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX 1 and increase islet size in mouse pancreas. Diabetes, 49:741-8
111. Stoffers DA, Desai BM, DeLeon DD, Simmons RA. (2003). Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes, 52:734-40
112. Ta M, Choi Y, Atouf F, et al. (2006). The defined combination of growth factors controls generation of long-Term-replicating islet progenitorlike cells from cultures of adult mouse pancreas. Stem Cells, 24: 1738-49
113. Takeda Y, Fujita Y, Honjo J, et al. (2012). Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice. Diabetologia, 55:404-12
114. Teta M, Long SY, Wartschow LM, et al. (2005). Very slow turnover of b-cells in aged adult mice. Diabetes, 54:2557-67
115. Teta M, Rankin MM, Long SY, et al. (2007). Growth and regeneration of adult Beta cells does not involve specialized progenitors. Dev Cell, 12: 817-26
116. Thorel F, Népote V, Avril I, et al. (2010). Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature, 464: 1149-54
117. Todorov I, Omori K, Pascual M, et al. (2006). Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation. Pancreas, 32: 130-8
118. Tourrel C, Bailbe D, Meile MJ, et al. (2001). Glucagon-like peptide-1 and exendin 4 stimulate beta-cell neogenesis in streptozotocin-Treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes, 50:1562-70
119. Trümper A, Trümper K, Trusheim H, et al. (2001). Glucose-Dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol, 15:1559-70
120. Trümper A, Trümper K, Hörsch D. (2002). Mechanisms of mitogenic and antiapoptotic signaling by glucose-Dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol, 174:233-46
121. Trümper J, Ross D, Jahr H, et al. (2005). The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells. Diabetologia, 48:1534-40
122. Tschen SI, Dhawan S, Gurlo T, Bhushan A. (2009). Age-Dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes, 58:1312-20
123. Tsunekawa S, Yamamoto N, Tsukamoto K, et al. (2007). Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol, 193:65-74
124. Wang Q, Brubaker PL. (2002). Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia, 45: 1263-73
125. Wang Q, Li L, Xu E, et al. (2004). Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells. Diabetologia, 47:478-87
126. Westermark P, Wilander E. (1978). The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia, 15: 417-21
127. Wettergren A, Pridal L, Wojdemann M, Holst JJ. (1998). Amidated and non-Amidated glucagon-like peptide-1 (GLP-1): Non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans. Regul Pept, 77:83-7
128. Widenmaier SB, Ao Z, Kim SJ, et al. (2009a). Suppression of p38 MAPK and JNK via Akt-mediated inhibition of apoptosis signalregulating kinase 1 constitutes a core component of the beta-cell pro-survival effects of glucose-Dependent insulinotropic polypeptide. J Biol Chem 284, 30372e30382
129. Widenmaier SB, Sampaio AV, Underhill TM, McIntosh CH. (2009b). Noncanonical activation of Akt/protein kinase B in {beta}-cells by the incretin hormone glucosedependent insulinotropic polypeptide. J Biol Chem 284, 10764e10773
130. Widenmaier SB, Kim SJ, Yang GK, et al. (2010). A GIP receptor agonist exhibits beta-cell anti-Apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One [Online] Available at: Http://www.plosone.org/article/ info%3Adoi%2F10.1371%2Fjournal.pone.0009590 [last accessed 9 Mar 2010].
131. Williams A, Jahreiss L, Sarkar S, et al. (2006). Aggregate-prone proteins are cleared from the cytosol by autophagy: Herapeutic implications. Curr Top Dev Biol, 76:89-101
132. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. (1999). Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes, 48:2270-6
133. Xu X, D'Hoker J, Stangé G, et al. (2008). Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell, 132:197-207
134. Yoon KH, Ko SH, Cho JH, et al. (2003). Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes in Korea. J Clin Endocrinol Metab, 88:2300-8
135. Yusta B, Baggio LL, Estall JL, et al. (2006). GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab, 4:391-406
136. Zhang X, Gaspard JP, Mizukami Y, et al. (2005). Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes, 54:712-19
137. Zhou J, Wang X, Pineyro MA, Egan JM. (1999). Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon-And insulinproducing cells. Diabetes, 48:2358-66
138. Zhou J, Pineyro MA, Wang X, et al. (2002). Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX-1 and HNF3beta transcription factors. J Cell Physiol, 192: 304-14
139. Zhou Q, Brown J, Kanarek A, et al. (2008). In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature, 455:627-32
140. Zulewski H, Abraham EJ, Gerlach MJ, et al. (2001). Multipotential nestinpositive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 50:521-33
141. Zunz E, La Barre J. (1929). Contributiona a l'etude des variations physiologiques de la secretion interne du pancreas. relations entre les secretions externe et interne du pancreas. Arch Int Physiol Biochim, 31:20-44